Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates. by Rupniak, N, Tye, S, Brazell, C, Heald, A, Iversen, S, Pagella, P

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all cause mortality by Anderson, S, Woodward, M, Rahimi, K, Hutchings, D, Rutter, M, Kirby, M, Hackett, G, Trafford, A, Heald, A

Mortality rate associated with diabetes: outcomes from a general practice level analysis in England using the Royal College of General Practitioners (RCGP) database indicate stabil... by Heald, A, Stedman, M, Robinson, A, Davies, M, Livingston, M, Alshames, R, Moreno, G, Gadsby, R, Rayman, G, Gibson, M, de Lusignan, S, Whyte, M

Effect of the COVID-19 pandemic on mental health visits in primary care: an interrupted time series analysis from nine INTRePID countries by Silva-Valencia, J, Lapadula, C, Westfall, JM, Gaona, G, de Lusignan, S, Kristiansson, RS, Ling, ZJ, Goh, LH, Soto-Becerra, P, Cuba-Fuentes, MS, Wensaas, K-A, Flottorp, S, Baste, V, Chi-Wai Wong, W, Pui Ng, AP, Ortigoza, A, Manski-Nankervis, J-A, Hallinan, CM, Zingoni, P, Scattini, L, Heald, A, Tu, K